Do specific virus–bacteria pairings drive clinical outcomes of pneumonia?

Laennec, 1923, 88 Simonsen, 2003, Estimating deaths due to influenza and respiratory syncytial virus, JAMA, 289, 2499, 10.1001/jama.289.19.2499-b Nolte, 2008, Molecular diagnostics for detection of bacterial and viral pathogens in community-acquired pneumonia, Clin Infect Dis, 47, S123, 10.1086/591392 Centers for Disease Control, 2009, Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1)—United States, May–August 2009, MMWR, 58, 1071 Stohr, 2003, Preventing and treating influenza, BMJ, 326, 1223, 10.1136/bmj.326.7401.1223 Simonsen, 1999, The global impact of influenza on morbidity and mortality, Vaccine, 17, S3, 10.1016/S0264-410X(99)00099-7 McCullers, 2006, Insights into the interaction between influenza virus and pneumococcus, Clin Microbiol Rev, 19, 571, 10.1128/CMR.00058-05 McCullers, 2011, Preventing and treating secondary bacterial infections with antiviral agents, Antivir Ther, 16, 123, 10.3851/IMP1730 Morens, 2008, Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness, J Infect Dis, 198, 962, 10.1086/591708 Chien, 2009, Bacterial pathogens and death during the 1918 influenza pandemic, N Engl J Med, 361, 2582, 10.1056/NEJMc0908216 Gill, 2010, Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections, Arch Pathol Lab Med, 134, 235, 10.5858/134.2.235 Dominguez-Cherit, 2009, Critically ill patients with 2009 influenza A(H1N1) in Mexico, JAMA, 302, 1880, 10.1001/jama.2009.1536 Mauad, 2010, Lung pathology in fatal novel human influenza A (H1N1) infection, Am J Respir Crit Care Med, 181, 72, 10.1164/rccm.200909-1420OC Estenssoro, 2010, Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation, Am J Respir Crit Care Med, 182, 41, 10.1164/201001-0037OC Shieh, 2010, The 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States, Am J Pathol, 177, 166, 10.2353/ajpath.2010.100115 Palacios, 2009, Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza, PLoS ONE, 4, e8540, 10.1371/journal.pone.0008540 Michelow, 2004, Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children, Pediatrics, 113, 701, 10.1542/peds.113.4.701 Berkley, 2010, Viral etiology of severe pneumonia among Kenyan infants and children, JAMA, 303, 2051, 10.1001/jama.2010.675 Olsen, 2010, Incidence of respiratory pathogens in persons hospitalized with pneumonia in two provinces in Thailand, Epidemiol Infect, 138, 1811, 10.1017/S0950268810000646 Hammitt, 2012, A preliminary study of pneumonia etiology among hospitalized children in Kenya, Clin Infect Dis, 54, S190, 10.1093/cid/cir1071 Chen, 2012, Etiology of community-acquired pneumonia in hospitalized children in northern Taiwan, Pediatr Infect Dis J, 31, e196, 10.1097/INF.0b013e31826eb5a7 Lamarao, 2012, Prevalence and clinical features of respiratory syncytial virus in children hospitalized for community-acquired pneumonia in northern Brazil, BMC Infect Dis, 12, 119, 10.1186/1471-2334-12-119 McCullers, 2012, Correlates of vaccine protection from influenza and its complications, Human Vaccines Immunotherapeutics, 8, 1, 10.4161/hv.8.1.18214 Martin, 1959, Asian influenza A in Boston, 1957–1958. I. Observations in thirty-two influenza-associated fatal cases, AMA Arch Intern Med, 103, 515, 10.1001/archinte.1959.00270040001001 Oseasohn, 1959, Clinicopathologic study of thirty-three fatal cases of Asian influenza, N Engl J Med, 260, 509, 10.1056/NEJM195903122601101 Louria, 1959, Studies on influenza in the pandemic of 1957–58. II. Pulmonary complications of influenza, J Clin Invest, 38, 213, 10.1172/JCI103791 Finelli, 2008, Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection, Pediatrics, 122, 805, 10.1542/peds.2008-1336 Chaussee, 2011, Inactivated and live, attenuated influenza vaccines protect mice against influenza: Streptococcus pyogenes super-infections, Vaccine, 29, 3773, 10.1016/j.vaccine.2011.03.031 Jennings, 2008, Incidence and characteristics of viral community-acquired pneumonia in adults, Thorax, 63, 42, 10.1136/thx.2006.075077 Watt, 2010, Use of serology and urine antigen detection to estimate the proportion of adult community-acquired pneumonia attributable to Streptococcus pneumoniae., Epidemiol Infect, 138, 1796, 10.1017/S0950268810000555 Brundage, 2008, Deaths from bacterial pneumonia during 1918–19 influenza pandemic, Emerg Infect Dis, 14, 1193, 10.3201/eid1408.071313 McCullers, 2002, Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor, J Infect Dis, 186, 341, 10.1086/341462 Alymova, 2005, The novel parainfluenza virus hemagglutinin-neuraminidase inhibitor BCX 2798 prevents lethal synergism between a paramyxovirus and Streptococcus pneumoniae., Antimicrob Agents Chemother, 49, 398, 10.1128/AAC.49.1.398-405.2005 Kukavica-Ibrulj, 2009, Infection with human metapneumovirus predisposes mice to severe pneumococcal pneumonia, J Virol, 83, 1341, 10.1128/JVI.01123-08 Stark, 2006, Decreased bacterial clearance from the lungs of mice following primary respiratory syncytial virus infection, J Med Virol, 78, 829, 10.1002/jmv.20631 Iverson, 2011, Influenza virus primes mice for pneumonia from Staphylococcus aureus, J Infect Dis, 203, 880, 10.1093/infdis/jiq113 Lee, 2010, A postinfluenza model of Staphylococcus aureus pneumonia, J Infect Dis, 201, 508, 10.1086/650204 Lee, 2010, A mouse model of lethal synergism between influenza virus and Haemophilus influenzae., Am J Pathol, 176, 800, 10.2353/ajpath.2010.090596 Karlstrom, 2009, Treatment with protein synthesis inhibitors improves outcomes of secondary bacterial pneumonia after influenza, J Infect Dis, 199, 311, 10.1086/596051 McCullers, 2008, Improving therapeutic strategies for secondary bacterial pneumonia following influenza, Future Microbiol, 3, 397, 10.2217/17460913.3.4.397 McAuley, 2010, PB1-F2 proteins from H5N1 and 20th century pandemic influenza viruses cause immunopathology, PLoS Pathog, 6, e1001014, 10.1371/journal.ppat.1001014 Taubenberger, 2010, Influenza virus evolution, host adaptation, and pandemic formation, Cell Host Microbe, 7, 440, 10.1016/j.chom.2010.05.009 Peltola, 2004, Respiratory viruses predisposing to bacterial infections: role of neuraminidase, Pediatr Infect Dis J, 23, S87, 10.1097/01.inf.0000108197.81270.35 Vigerust, 2007, N-Linked glycosylation attenuates H3N2 influenza viruses, J Virol, 81, 8593, 10.1128/JVI.00769-07 McAuley, 2007, Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia, Cell Host Microbe, 2, 240, 10.1016/j.chom.2007.09.001 McCullers, 2003, Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae., J Infect Dis, 187, 1000, 10.1086/368163 Alymova, 2011, Immunopathogenic and anti-bacterial effects of the H3N2 influenza A virus PB1-F2 map to amino acid residues 62, 75, 79, and 82, J Virol, 85, 12324, 10.1128/JVI.05872-11 Hai, 2010, PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models, J Virol, 84, 4442, 10.1128/JVI.02717-09 Weeks-Gorospe, 2012, Naturally occurring swine influenza A virus PB1-F2 phenotypes that contribute to superinfection with Gram-positive respiratory pathogens, J Virol, 86, 9035, 10.1128/JVI.00369-12 McCullers, 2010, Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets, J Infect Dis, 202, 1287, 10.1086/656333 Kumar, 2010, Clinical and epidemiologic characteristics of children hospitalized with 2009 pandemic H1N1 influenza A infection, Pediatr Infect Dis J, 29, 591, 10.1097/INF.0b013e3181d73e32